# Corchorus olitorius exhibits antiproliferative potential supported by metabolic profiling and integrative biological analyses

**Authors:** Salma Sameh, Maha R. A. Abdollah, Ahmed M. Elissawy, Eman Al-Sayed, Rola M. Labib, Lan Ye, Fang-Rong Chang, Abdel Nasser B. Singab

PMC · DOI: 10.1038/s41598-025-02717-1 · 2025-05-25

## TL;DR

Corchorus olitorius leaves show anticancer potential in lab and animal studies, with identified compounds that bind well to cancer-related proteins.

## Contribution

The study demonstrates the antiproliferative and anti-angiogenic potential of Corchorus olitorius and identifies bioactive compounds with drug-like properties.

## Key findings

- The bioactive fraction of Corchorus olitorius showed strong in vitro antiproliferative activity against A549 cells with an IC50 of 7.8 µg/mL.
- In vivo experiments showed a 33.7% reduction in tumor volume in mice treated with the fraction.
- UPLC-ESI-MS/MS identified 25 compounds with favorable binding affinities to EGFR, CDK2, and VEGF-A.

## Abstract

Herbal nutraceuticals could be employed as alternative or complementary routes for alleviating cancer. Corchorus olitorius (Malvaceae) was employed traditionally in the management of tumors. The study aimed to investigate the antiproliferative activity of C. olitorius leaves. In vitro cytotoxic and anti-angiogenic activities of C. olitorius were estimated. The bioactive fraction was subjected to in vivo study on BALB/ c female mice using Ehrlich Ascites Carcinoma model. UPLC-ESI-MS/MS analysis was done to determine the phytometabolites followed by in silico studies on the major identified compounds. The bioactive fraction possessed potent in vitro activity against A549 cells with IC50 = 7.8 µg/mL and exhibited strong anti-angiogenic activity. The in vivo study revealed the safety of the fraction and confirmed its anticancer activity. The tumor volume in the fraction treated group was reduced by 33.7% compared to the control group. UPLC-ESI-MS/MS analysis led to the identification of 25 compounds belonging to different chemical classes. The in silico pharmacodynamic profile revealed that the compounds exhibited agreeable binding affinities toward EGFR, CDK2 and VEGF-A comparable to the standard drugs. C. olitorius is a promising herbal nutraceutical from which effective chemopreventive and anticancer formulations can be developed following further in depth studies.

## Linked entities

- **Proteins:** EGFR (epidermal growth factor receptor), CDK2 (cyclin dependent kinase 2), VEGFA (vascular endothelial growth factor A)
- **Diseases:** cancer (MONDO:0004992)
- **Species:** Corchorus olitorius (taxon 93759), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** Ehrlich Ascites Carcinoma (MESH:D002286), cytotoxic (MESH:D064420), cancer (MESH:D009369)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Corchorus olitorius (Nalta jute, species) [taxon 93759]
- **Cell lines:** A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12104385/full.md

---
Source: https://tomesphere.com/paper/PMC12104385